High-Dose Therapy and Autologous Stem Cell Transplantation for Chemoresistant Hodgkin Lymphoma: The Seattle Experience

BACKGROUND: High-dose therapy (HDT) with autologous stem cell transplantation (ASCT) is the standard treatment for patients with chemosensitive relapsed/refractory Hodgkin lymphoma (HL), but this therapy is commonly denied to patients with resistant disease. We explored the utility of HDT and ASCT f...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Gopal, Ajay K, Metcalfe, Tracee L, Gooley, Ted A, Pagel, John M, Petersdorf, Stephen H, Bensinger, William I, Holmberg, Leona, Maloney, David G, Press, Oliver W
Format: Artigo
Idioma:Inglês
Publicat: 2008
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2700660/
https://ncbi.nlm.nih.gov/pubmed/18623377
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.23715
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars